The Oscillution platform enables in vitro testing with a dual purpose: to disclose potential adverse effects of non-brain-targeting drugs and to assess the potency and efficacy of brain-targeting drugs, thereby increasing the predictability of effective and save drug doses in clinical trials.
Contact us to discover how analysing local field potentials, oscillatory activity, spiking, and network bursting offers a more comprehensive understanding of how drugs modulate human brain cell electrical function.